CureVac N.V. Stock News
$2.84
0.61%
today
Nasdaq,
Apr 03, 05:19 pm CET
CureVac N.V. Stock News
Positive
Market Watch
●
6 days ago
Shares of CureVac climbed after the European Patent Office confirmed the validity of a patent that has been the subject of a lawsuit filed by BioNTech.
Positive
Reuters
●
7 days ago
The European Patent Office declared a patent owned by CureVac , valid, after a challenge from drugmaker BioNTech , the company said on Thursday.
Neutral
Accesswire
●
7 days ago
European Patent Office largely dismisses opposition filed by BioNTech SE in April 2023 challenging validity of EP 3 708 668 B1 and maintains the patent in amended form A hearing on infringement of EP 3 708 668 B1 is scheduled for July 1, 2025, before the Regional Court Düsseldorf Confirming validity of patent in its amended form marks major milestone in broader patent litigation in Germany, rec...
AD HOC NEWS
●
8 days ago
CureVac / NL0015436031
AD HOC NEWS
●
8 days ago
CureVac / NL0015436031
Neutral
Accesswire
●
about one month ago
CureVac among global top 100 most fast-paced innovators for third consecutive year in acknowledgment of its innovative strength and extensive intellectual property portfolio The company holds one of the broadest intellectual property portfolios in mRNA technology TÜBINGEN, GERMANY AND BOSTON, MA / ACCESS Newswire / February 18, 2025 / CureVac N.V. (Nasdaq:CVAC), a global biopharmaceutical compa...
AD HOC NEWS
●
about one month ago
CureVac / NL0015436031
AD HOC NEWS
●
about one month ago
CureVac erneut von LexisNexis® als eines der weltweit führenden Innovationsunternehmen ausgezeichnet
CureVac / NL0015436031
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
